North Dallas Radiation Onclgy is categorized under Primary Care Centers in Plano, TX and active since 2009.
North Dallas Radiation Onclgy was established in 2009, and today employs 1 to 4, earning Unknown per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Manoj Reddy at the company’s single location by writing to 5948 West Parker Road, Plano, Texas TX 75093 or by phoning (972) 941-3821. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | North Dallas Radiation Onclgy |
| Contact Person: | Manoj Reddy |
| Address: | 5948 West Parker Road, Plano, Texas 75093 |
| Phone Number: | (972) 941-3821 |
| Website Address: | northdallasradiationoncology.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Primary Care Centers |
| SIC Code: | 8011 |
| NAICS Code: | 5417112 |
| Share This Business: |
North Dallas Radiation Onclgy was started in 2009 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Manoj Reddy for inquiries that concern North Dallas Radiation Onclgy by calling the company number (972) 941-3821, as your correspondence is most welcome. Additionally, the physical location of the single location of North Dallas Radiation Onclgy can be found at the coordinates 33.04518,-96.82581 as well as the street address 5948 West Parker Road in Plano, Texas 75093.
For its online presence, you may visit North Dallas Radiation Onclgy’s website at northdallasradiationoncology.com and engage with its social media outlets through on Twitter and on Facebook.